cyclohexanol has been researched along with nortriptyline in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (11.54) | 18.2507 |
| 2000's | 12 (46.15) | 29.6817 |
| 2010's | 11 (42.31) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jenkins, AJ; Jufer, R; Levine, B; Queen, M; Smialek, JE | 1 |
| Benazzi, F | 1 |
| Borgherini, G; Conforti, D; Fiorellini Bernardis, LA; Magni, G | 1 |
| Gastó, C; Marcos, T; Navarro, V; Portella, MJ; Rodamilans, M; Torra, M | 1 |
| Basinski, J; Begley, A; Dew, MA; Farhi, P; Mulsant, BH; Reynolds, CF; Whyte, EM | 1 |
| de Leeuw, FE; Heeren, TJ; Hulshoff Pol, HE; Janssen, J; Kahn, RS; Kok, RM; Lampe, IK; Schnack, HG | 1 |
| Heeren, TJ; Kok, RM; Nolen, WA | 2 |
| Heeren, T; Kok, R; Nolen, W | 2 |
| Dekker, J; Peen, J; Schoevers, RA; van Aalst, G; Van, HL | 1 |
| Campbell, GM; Case, M; Corya, SA; Henley, DB; Osuntokun, O; Thase, ME; Trivedi, MH; Watson, SB | 1 |
| Heeren, TJ; Kok, RM; Nolen, WA; van Baarsen, C | 1 |
| Cooper, T; Dillingham, EM; Garcia, K; Haskett, RF; Isenberg, K; McCall, WV; Mulsant, BH; Prudic, J; Rosenquist, P; Sackeim, HA | 1 |
| Benedet, J; Carvalho-Silva, M; Jeremias, GC; Quevedo, J; Rezin, GT; Rochi, N; Santos, PM; Scaini, G; Streck, EL | 1 |
| Aartsen, M; Heeren, T; Kok, RM; Nolen, WA | 1 |
| Benedet, J; Borges, LS; Gomes, LM; Pezente, DP; Quevedo, J; Rezin, GT; Rochi, N; Santos, PM; Scaini, G; Streck, EL | 1 |
| Haskett, R; Isenberg, K; Kimball, J; Lasater, B; McCall, WV; Prudic, J; Rosenquist, PB; Sackeim, HA | 1 |
| Macaluso, M; Preskorn, SH | 1 |
| Fulda, S; Himmerich, H; Plümäkers, B; Rink, L; Sheldrick, AJ | 1 |
| Cooper, T; Haskett, RF; Isenberg, K; McCall, WV; Mulsant, BH; Prudic, J; Rosenquist, PB; Sackeim, HA | 1 |
| Chua, EW; Foulds, J; Kennedy, MA; Miller, AL | 1 |
| Al Hadithy, AF; Birkenhager, TK; Koch, BC | 1 |
| Bouckaert, F; Kho, KH; Kok, RM; Sienaert, P; Spaans, HP; Stek, ML; van den Berg, JF; Verwijk, E | 2 |
| Geduldig, ET; Greenberg, RM; Husain, MM; Kellner, CH; Knapp, RG; Lisanby, SH; McCall, WV; Petrides, G; Prudic, J; Rudorfer, MV; Weiner, RD; Young, RC | 1 |
2 review(s) available for cyclohexanol and nortriptyline
| Article | Year |
|---|---|
CYP 2D6 PM status and antidepressant response to nortriptyline and venlafaxine: is it more than just drug metabolism?
Topics: Antidepressive Agents; Catalysis; Cyclohexanols; Cytochrome P-450 CYP2D6; Depressive Disorder; Humans; Nortriptyline; Substrate Specificity; Treatment Outcome; Venlafaxine Hydrochloride | 2011 |
Pharmacological strategies in the prevention of relapse after electroconvulsive therapy.
Topics: Adult; Aged; Analysis of Variance; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Diagnostic and Statistical Manual of Mental Disorders; Drug Resistance; Educational Status; Electroconvulsive Therapy; Female; Humans; Kaplan-Meier Estimate; Lithium Carbonate; Male; Middle Aged; Nortriptyline; Psychiatric Status Rating Scales; Recurrence; Survival Analysis; Venlafaxine Hydrochloride | 2013 |
11 trial(s) available for cyclohexanol and nortriptyline
| Article | Year |
|---|---|
Single-blind comparison of venlafaxine and nortriptyline in elderly major depression.
Topics: Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder, Major; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Nortriptyline; Psychiatric Status Rating Scales; Single-Blind Method; Venlafaxine Hydrochloride | 2003 |
Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Combined Modality Therapy; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Female; Geriatric Assessment; Humans; Lithium; Male; Nortriptyline; Paroxetine; Psychiatric Status Rating Scales; Psychotherapy; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Cerebral volume measurements and subcortical white matter lesions and short-term treatment response in late life depression.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Brain; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Leukoaraiosis; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Fibers, Myelinated; Nortriptyline; Venlafaxine Hydrochloride | 2007 |
Venlafaxine versus nortriptyline in the treatment of elderly depressed inpatients: a randomised, double-blind, controlled trial.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Nortriptyline; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 2007 |
Outcome of late-life depression after 3 years of sequential treatment.
Topics: Age of Onset; Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Follow-Up Studies; Humans; Nortriptyline; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Early response as predictor of final remission in elderly depressed patients.
Topics: Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder, Major; Humans; Middle Aged; Nortriptyline; Remission Induction; ROC Curve; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Effect of concomitant pharmacotherapy on electroconvulsive therapy outcomes: short-term efficacy and adverse effects.
Topics: Adult; Aged; Antidepressive Agents; Combined Modality Therapy; Cross-Over Studies; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Electroconvulsive Therapy; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Nortriptyline; Prospective Studies; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
The course of adverse effects of nortriptyline and venlafaxine in elderly patients with major depression.
Topics: Age Factors; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Comorbidity; Cross-Sectional Studies; Cyclohexanols; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Hospitals, Psychiatric; Humans; Male; Middle Aged; Netherlands; Nortriptyline; Personality Assessment; Risk Factors; Venlafaxine Hydrochloride | 2009 |
Health-related quality of life in a clinical trial of ECT followed by continuation pharmacotherapy: effects immediately after ECT and at 24 weeks.
Topics: Antidepressive Agents; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Electroconvulsive Therapy; Female; Humans; Lithium; Male; Middle Aged; Nortriptyline; Quality of Life; Time Factors; Venlafaxine Hydrochloride | 2011 |
Pharmacological strategies in the prevention of relapse after electroconvulsive therapy.
Topics: Adult; Aged; Analysis of Variance; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Diagnostic and Statistical Manual of Mental Disorders; Drug Resistance; Educational Status; Electroconvulsive Therapy; Female; Humans; Kaplan-Meier Estimate; Lithium Carbonate; Male; Middle Aged; Nortriptyline; Psychiatric Status Rating Scales; Recurrence; Survival Analysis; Venlafaxine Hydrochloride | 2013 |
Speed of remission in elderly patients with depression: electroconvulsive therapy v. medication.
Topics: Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Humans; Male; Nortriptyline; Remission Induction; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2015 |
14 other study(ies) available for cyclohexanol and nortriptyline
| Article | Year |
|---|---|
Distribution of venlafaxine in three postmortem cases.
Topics: Acetaminophen; Adult; Amitriptyline; Antidepressive Agents, Second-Generation; Bile; Chlordiazepoxide; Chromatography, Gas; Cyclohexanols; Diphenhydramine; Humans; Kidney; Liver; Male; Methylation; Middle Aged; Nortriptyline; Reference Standards; Selective Serotonin Reuptake Inhibitors; Suicide; Venlafaxine Hydrochloride | 1996 |
Venlafaxine-fluoxetine-nortriptyline interaction.
Topics: Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Nortriptyline; Venlafaxine Hydrochloride | 1997 |
Extrapyramidal symptoms associated with the adjunct of nortriptyline to a venlafaxine-valproic acid combination.
Topics: Aged; Anticonvulsants; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Basal Ganglia Diseases; Bipolar Disorder; Cyclohexanols; Drug Combinations; Drug Interactions; Humans; Male; Nortriptyline; Valproic Acid; Venlafaxine Hydrochloride | 1999 |
Cardiovascular changes associated with venlafaxine in the treatment of late-life depression.
Topics: Aged; Antidepressive Agents, Second-Generation; Blood Pressure; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Electrocardiography; Female; Heart Rate; Humans; Male; Nortriptyline; Randomized Controlled Trials as Topic; Venlafaxine Hydrochloride | 2007 |
Identifying patients at risk of complete nonresponse in the outpatient treatment of depression.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Amitriptyline; Antidepressive Agents; Combined Modality Therapy; Cyclohexanols; Data Interpretation, Statistical; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Resistance; Female; Humans; Male; Middle Aged; Nortriptyline; Psychotherapy; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Severity of Illness Index; Venlafaxine Hydrochloride; Young Adult | 2008 |
An integrated analysis of olanzapine/fluoxetine combination in clinical trials of treatment-resistant depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Nortriptyline; Olanzapine; Personality Inventory; Psychometrics; Randomized Controlled Trials as Topic; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Brain creatine kinase activity is increased by chronic administration of paroxetine.
Topics: Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Brain; Corpus Striatum; Creatine Kinase, BB Form; Cyclohexanols; Hippocampus; Male; Nortriptyline; Paroxetine; Prefrontal Cortex; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2009 |
Evaluation of Krebs cycle enzymes in the brain of rats after chronic administration of antidepressants.
Topics: Animals; Antidepressive Agents; Brain; Citrate (si)-Synthase; Citric Acid Cycle; Cyclohexanols; Male; Nortriptyline; Paroxetine; Rats; Rats, Wistar; Succinate Dehydrogenase; Venlafaxine Hydrochloride | 2010 |
Treatment of psychotic depression in the elderly compared with nonpsychotic depression.
Topics: Affective Disorders, Psychotic; Aged; Antidepressive Agents; Antipsychotic Agents; Cyclohexanols; Depressive Disorder, Major; Follow-Up Studies; Humans; Middle Aged; Nortriptyline; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
IFN-gamma reduction by tricyclic antidepressants.
Topics: Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Cytokines; Depressive Disorder; Desipramine; Desvenlafaxine Succinate; Female; Humans; Imipramine; In Vitro Techniques; Interferon-gamma; Male; Nortriptyline; Venlafaxine Hydrochloride | 2010 |
Novel CYP2D6 and CYP2C19 variants identified in a patient with adverse reactions towards venlafaxine monotherapy and dual therapy with nortriptyline and fluoxetine.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Aryl Hydrocarbon Hydroxylases; Base Sequence; Cyclohexanols; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Haplotypes; Humans; Molecular Sequence Data; Nortriptyline; Polymorphism, Genetic; Sequence Analysis, DNA; Venlafaxine Hydrochloride; Young Adult | 2013 |
Cytochrome P450 2D6 poor metabolism, curvilinearity, and response: an intriguing observation requiring integration of psychopharmacology into pharmacogenetics.
Topics: Antidepressive Agents; Cyclohexanols; Cytochrome P-450 CYP2D6; Depressive Disorder; Humans; Nortriptyline | 2013 |
More data on speed of remission with ECT in geriatric depression.
Topics: Cyclohexanols; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Humans; Male; Nortriptyline | 2015 |
Authors' reply.
Topics: Cyclohexanols; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Humans; Male; Nortriptyline | 2015 |